100 related articles for article (PubMed ID: 16170367)
1. The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase.
Linggi B; Cheng QC; Rao AR; Carpenter G
Oncogene; 2006 Jan; 25(1):160-3. PubMed ID: 16170367
[TBL] [Abstract][Full Text] [Related]
2. HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4.
Strunk KE; Husted C; Miraglia LC; Sandahl M; Rearick WA; Hunter DM; Earp HS; Muraoka-Cook RS
Cancer Res; 2007 Jul; 67(14):6582-90. PubMed ID: 17638867
[TBL] [Abstract][Full Text] [Related]
3. gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase.
Ni CY; Murphy MP; Golde TE; Carpenter G
Science; 2001 Dec; 294(5549):2179-81. PubMed ID: 11679632
[TBL] [Abstract][Full Text] [Related]
4. The ErbB/HER receptor protein-tyrosine kinases and cancer.
Roskoski R
Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
[TBL] [Abstract][Full Text] [Related]
5. ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression.
Linggi B; Carpenter G
J Biol Chem; 2006 Sep; 281(35):25373-80. PubMed ID: 16815842
[TBL] [Abstract][Full Text] [Related]
6. Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment.
Arasada RR; Carpenter G
J Biol Chem; 2005 Sep; 280(35):30783-7. PubMed ID: 15985438
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.
Thiel KW; Carpenter G
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19238-43. PubMed ID: 18042729
[TBL] [Abstract][Full Text] [Related]
8. The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.
Feng SM; Sartor CI; Hunter D; Zhou H; Yang X; Caskey LS; Dy R; Muraoka-Cook RS; Earp HS
Mol Endocrinol; 2007 Aug; 21(8):1861-76. PubMed ID: 17505063
[TBL] [Abstract][Full Text] [Related]
9. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.
Muraoka-Cook RS; Sandahl M; Husted C; Hunter D; Miraglia L; Feng SM; Elenius K; Earp HS
Mol Biol Cell; 2006 Sep; 17(9):4118-29. PubMed ID: 16837552
[TBL] [Abstract][Full Text] [Related]
10. An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.
McLaughlin S; Smith SO; Hayman MJ; Murray D
J Gen Physiol; 2005 Jul; 126(1):41-53. PubMed ID: 15955874
[TBL] [Abstract][Full Text] [Related]
11. Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulin.
Kani K; Warren CM; Kaddis CS; Loo JA; Landgraf R
J Biol Chem; 2005 Mar; 280(9):8238-47. PubMed ID: 15611073
[TBL] [Abstract][Full Text] [Related]
12. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
Wu CJ; Qian X; O'Rourke DM
DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
[TBL] [Abstract][Full Text] [Related]
13. Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains.
Sundvall M; Peri L; Määttä JA; Tvorogov D; Paatero I; Savisalo M; Silvennoinen O; Yarden Y; Elenius K
Oncogene; 2007 Oct; 26(48):6905-14. PubMed ID: 17486069
[TBL] [Abstract][Full Text] [Related]
14. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
Liu SM; Carpenter G
J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin.
Yoo JY; Wang XW; Rishi AK; Lessor T; Xia XM; Gustafson TA; Hamburger AW
Br J Cancer; 2000 Feb; 82(3):683-90. PubMed ID: 10682683
[TBL] [Abstract][Full Text] [Related]
17. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation.
Vecchi M; Baulida J; Carpenter G
J Biol Chem; 1996 Aug; 271(31):18989-95. PubMed ID: 8702564
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the N-terminal unique domain of Chk tyrosine kinase in Chk-induced tyrosine phosphorylation in the nucleus.
Nakayama Y; Kawana A; Igarashi A; Yamaguchi N
Exp Cell Res; 2006 Jul; 312(12):2252-63. PubMed ID: 16707123
[TBL] [Abstract][Full Text] [Related]
19. ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo.
Muraoka-Cook RS; Sandahl MA; Strunk KE; Miraglia LC; Husted C; Hunter DM; Elenius K; Chodosh LA; Earp HS
Mol Cell Biol; 2009 Sep; 29(18):4935-48. PubMed ID: 19596786
[TBL] [Abstract][Full Text] [Related]
20. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
